Διερεύνηση σηπτικών φλεγμονών επί εδάφους ολικής αρθροπλαστικής ισχίου με ραδιοεπισημασμένα μονοκλωνικά αντισώματα (LeukoScan)

Abstract

AIM: Nuclear Medicine can contribute in differential diagnosis of septic loosening of hip arthroplasty, when the clinical and laboratory findings are not clear. The aim of this study was to determine the ability of scintigraphy with 99mΤc–Sulesomab (LeukoScan®), to diagnose and localize periprosthetic septic lesions in patients with hip arthroplasty. MATERIALS AND METHODS: 21 patients with hip arthroplasty (12 cementless, 3 cemented, 2 hybrid, 3 bipolar total hip arthroplasties and 1 semiarthroplasty) were studied between 1/2001 up to 2/2004, for possible periprosthetic inflammation and septic loosening. The mean follow up period was 4,4 years (2-12). 9 patients (42,8%), were subjected in revision arthroplasty, 8 patients in Girdlestone procedure, 3 patients in surgical debridement and 1 patient, with congenital hip luxation who was primary subjected in femoral shortening osteotomy and fixation with plate and screws, in revision of the fixation. Then mean patient age was 63 years (42-78) and the male to female ratio was 8:13. All patients, in order to be evaluated, had to fulfill the following requirements: 1) absence of pregnancy, 2) normal renal function, 3) 12 months period after the implantation of the primary prosthesis, 4) 3 weeks period free of antibiotic therapy, before the investigation with Leukoscan and 5) abnormal high values of ESR and CRP, since normal values exclude septic loosening. Patients’ selection for diagnostic evaluation was based on a “high risk protocol” in combination with clinical suspicion of periprothetic infection and septic loosening. All patients were clinically evaluated using Harris Hip Score and were investigated with standard x-rays and blood tests, including total white cell number, percentage of neutrophile granulocytes, ESR and CRP. During scintigraphic studies, 99mTc-Dynamic Bone was done before LeukoScan®, because of its high sensitivity for detecting infectious areas, its low cost and the current diagnostic strategy for doubtful cases of bone infection. LeukoScan® findings were classified in four distinct categories I – IV (I – with normal radiopharmaceutical concentration, II – increased uptake in soft tissues and normal in bone, III – equal increased uptake in soft tissues and bone, IV – increased bony uptake). Categories I and II represent negative LeukoScan® findings, while III and IV were classified as positive. Histopathologic and microbiologic tests of intraoperative samples were done (only positive microbiologic tests were evaluated). Histopathologic criterion for periprothetic septic loosening was considered the finding of >5 neutrophile granulocytes per high energy field. LeukoScan® findings were matched with histopathologic and microbiologic results. RESULTS: Patients’ preoperative evaluation revealed the following risk factors: hip or thigh pain (21 patients, 100%), pathologic blood tests (21 patients, 100%), previous operations (13 patients, 61,9%), wound infection (10 patients, 47,6%) and other infectious regions (9 patients, 42,8%). Preoperative Harris Hip Score was 64 points (28 – 93). Histologic and microbiologic tests of intraoperative samples revealed periprothetic infection in 17 cases. Mean value of laboratory tests revealing infection with respect to total white cells number was 8,6 Κ/μl ( 3,9 – 14,5 Κ/μl ), percentage of neutrophile granulocytes 64% (39 – 79%), ESR 56,3 mm (23 – 101 mm) and CRP 6,1 mg/dl. ESR showed a sensitivity of 1, accuracy 0,8 and positive prognostic value 0,8. CRP had 0,94, 0,25 and 0,8 respective values, with positive prognostic value 0,84. 15 Dynamic Bone Scan were done, 12 were classified as positive, 1 true negative and 2 false positive. LeukoScan® were classified as 17 true positive and 4 true negative. 7 true positive tests were classified in category III and 10 in category IV. 1 negative LeukoScan® was classified in category I and 3 in category II. Dynamic Bone Scan showed a sensitivity 1, specificity 0,33, accuracy 0,86, positive and negative prognostic value 0,85 and 1 respectively. 99mTc-Sulesomab showed for all parameters value 1. CONCLUSIONS: Following the appropriate diagnostic algorithm and patient selection, 99mTc-Sulesomab can detect septic loosening, since it shows sensitivity, specificity, accuracy, positive and negative prognostic values of 1. SPECT/CT-scan offers significant diagnostic help when infection is localized above the neck of the femoral component.